From carve-out to pan-European platform with CNX Therapeutics
Most pharma businesses are built on new drugs. CNX Therapeutics was built on the ones big pharma had overlooked. Carved out of US group Sunovion in 2021 with a single product, it now spans more than 60 countries, has grown to 25 products, and become the first UK pharmaceutical company to earn B Corp status. 💊
In this episode, CNX CEO Guy Clark joins host Tim Smallbone and Inflexion's Christian Fellowes to explore how a thesis first sketched on a napkin became a pan European platform, why so many effective medicines never reach the patients who need them, and how you scale from 17 people to nearly 70 without losing your culture.
21 Jul 2026
Rethinking AI as a superhuman, not software, with Greg Nieuwenhuys
Artificial intelligence will decide which businesses thrive over the next decade and which get left behind. But the biggest barrier is not the technology. It is people, culture, and leaders who have not yet seen what it can really do. 🤖
In this episode, Greg Nieuwenhuys, chair of Inflexion portfolio company Nodor and senior partner at AI advisory firm WAIMAKERS, joins Inflexion's Alex Mathers and host Tim Smallbone to explore what it takes to make AI stick in a business: why adoption has to be owned by the CEO, why the prize is reimagining your value proposition rather than cutting costs, and why human skills matter more than ever. 🧠
10 Jun 2026
Becoming Germany's go-to investment platform with Finanzen.net
In 1999, three students at the University of Karlsruhe built a free stock market platform because they couldn't afford the data they needed to invest. Twenty-five years later, Finanzen.net is Germany's number one financial media and investing platform, with 6 million monthly users, a free neobroker, and an ambitious vision to become the leading investment and savings platform across the DACH region. 📈
In this episode, co-founder Jens Ohr joins Inflexion Partner and Head of Financial Services Andrea Bertolini and host Tim Smallbone to tell that story, including the 2025 carve-out from Axel Springer that gave the business its independence. They explore why only one in five Germans invests in the stock market and how that is changing fast, what made Finanzen.net stand out to Inflexion, and how you find the right partner for a business you've spent 25 years building. Jens and Andrea also share why the ambition from here is to become the home for every investor across the DACH region.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Spotify
5.0 / 5
5 ratings
Podcast Authority Score: 21 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
18
Social presence
0
YouTube
0
Engagement
60
Contact Inflexion Point
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
